✦ LIBER ✦

Induction of anti-tumor immunity in vivo using cytokines and an agonistic antibody against 4-1BB

✍ Scribed by L. Borges; R.E. Miller; J. Jones; D.H. Lynch

Book ID: 117658441
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 354 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)81076-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The induction of tumor-specific CD4+ T c

The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells

✍ Yasuhiro Fujisawa; Tsukasa Nabekura; Tomohei Nakao; Yasuhiro Nakamura; Takenori 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 624 KB

Studies of the mechanisms for the induct

Studies of the mechanisms for the induction of in vivo tumor immunity. V. A comparison of the generation of the primary cell-mediated cytotoxic response using in vitro mixed-lymphocyte-tumor cell culture and an in vivo technique

✍ Dennis Rodrigues; Chou-Chik Ting 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 720 KB

Development of in vivo somatic mutation

Development of in vivo somatic mutation system using antibody against hemoglobin Preparation and use of an anti-hemoglobin antibody for identifying C57BL/6 red cells in artificial mixture of DBA/2 and C57BL/6 red cells

✍ Aftab A. Ansari; Masroor A. Baig; H.V. Malling 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 795 KB

Acquired immunity in nude mice induced b

Acquired immunity in nude mice induced by expression of the IL-2 or IL-4 gene in human pancreatic carcinoma cells and anti-tumor effect generated by In vivo gene transfer using retrovirus

✍ Masaki Kimura; Yu Yoshida; Mitsuro Narita; Keizo Takenaga; Toshinao Takenouchi; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 330 KB 👁 2 views

We have examined the anti-tumor effect in nude mice caused by human pancreatic cancer cells (AsPC-1) modified to secrete IL-2 or IL-4. Loss of tumorigenicity of cytokineproducing, but not wild-type, cells was observed despite their unaltered in vitro proliferation rates; and these anti-tumor effects